Commercialisation Representative

Associate Professor Kevin Pfleger is Head of Molecular Endocrinology and Pharmacology at the Harry Perkins Institute of Medical Research (‘Perkins’) and Centre for Medical Research, The University of Western Australia (UWA). He is a NHMRC RD Wright Biomedical Research Fellow (Level 2), as well as being Chief Scientific Advisor of ASX-listed Dimerix Limited, a spin-out company from the Perkins and UWA. He was Chief Scientific Officer of Dimerix Bioscience Pty Ltd from 2008-2014.

Kevin was awarded his MA and PhD from Cambridge and Edinburgh Universities respectively, and relocated to Western Australia in October 2002. He was a NHMRC Peter Doherty Research Fellow from 2005 to 2008 and an ARC Future Fellow from 2011 to 2014. Kevin has numerous national and international accolades, including NHMRC 10 of the Best Research Projects 2010, Australian Museum Eureka Prize for Emerging Leader in Science 2012, NHMRC Research Excellence Award 2014 and 2016 Novartis Prize of the British Pharmacological Society.

Kevin is Chair of the Executive Committee of Accelerating Australia, a life sciences consortium working to advance the biomedical innovation ecosystem across Australia, supported by the MedTech and Pharma Growth Centre (MTPConnect). He is also Chair of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Scientific Advisory Committee, member of the International Advisory Group of the British Pharmacological Society, and member of the WA State Committee of AusBiotech.